- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Obstructive Pulmonary Syndrom in United States
Total 3972 results
-
MedImmune LLCCompletedChronic Obstructive Pulmonary DiseaseUnited States, Bulgaria, Czech Republic, Poland, United Kingdom, Philippines, Latvia, Lithuania, Ukraine, Hungary
-
Queen's University, BelfastCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Respivert LtdCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Queen Mary University of LondonGlaxoSmithKline; British Lung FoundationCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Chiesi Farmaceutici S.p.A.Chiesi USA, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Czech Republic, Germany, Poland, Romania, South Africa
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
Baylor College of MedicineM.D. Anderson Cancer CenterCompleted
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)United States, Korea, Republic of, Argentina, Turkey, Vietnam, Malaysia, Philippines, Thailand, Hungary, Mexico, Canada, India, Bulgaria, Poland
-
Teesside UniversityRecruitingChronic Obstructive Pulmonary Disease | Healthy VolunteersUnited Kingdom
-
University of SouthamptonGlaxoSmithKlineCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
University of Alabama at BirminghamUS Department of Veterans Affairs; University of California, San Francisco; University...CompletedChronic Obstructive Pulmonary Disease | Congestive Heart FailureUnited States
-
Medicines Evaluation Unit LtdChiesi UKCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
SunovionCompleted
-
The University of Texas Health Science Center,...CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
NHS TaysideNHS FifeWithdrawnChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
Patrick MurphyResMed; ResMed Foundation; Guy's & St Thomas' Charity; Respironics InternationalCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
University of California, San DiegoTerminatedChronic Obstructive Pulmonary Disease | Copd | Chronic Respiratory Failure | Hypoventilation | HypercapniaUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Sweden, Ukraine, United Kingdom
-
University of LeicesterAparito Ltd.Not yet recruitingChronic Obstructive Pulmonary Disease | Adherence, TreatmentUnited Kingdom
-
Royal Brompton & Harefield NHS Foundation TrustUnknownChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
University of California, San FranciscoNational Institute of Nursing Research (NINR)CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseBulgaria, Germany, Poland, United Kingdom
-
Mrs Hanoof AljohaniUniversity Hospitals, LeicesterRecruitingChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
University of Southern CaliforniaPatient-Centered Outcomes Research InstituteTerminatedCancer | Chronic Obstructive Pulmonary Disease | Congestive Heart FailureUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Sunovion Respiratory Development Inc.Completed
-
Imperial College LondonCompletedChronic Obstructive Pulmonary Disease | Emphysema | Chronic BronchitisUnited Kingdom
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustNovartisCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
DeyCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
BioMarck Pharmaceuticals, Ltd.National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease | COPDUnited States
-
University of IowaNational Institute of Mental Health (NIMH)CompletedDepression | Heart Failure | Chronic Obstructive Pulmonary DiseaseUnited States
-
SanofiRegeneron PharmaceuticalsRecruitingChronic Obstructive Pulmonary DiseaseUnited States, Netherlands, Belgium, Denmark, Germany, United Kingdom, Brazil
-
DeyCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Valley Medical ResearchCompletedDepression | Chronic Obstructive Pulmonary DiseaseUnited States
-
Hoffmann-La RocheCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada, Bulgaria, Hungary, Russian Federation, Denmark, Argentina, Mexico, Poland
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDPoland, United Kingdom, Germany, Sweden, Denmark
-
Sociedad Española de Neumología y Cirugía TorácicaEuropean Commission; SAVANAUnknownChronic Obstructive Pulmonary DiseaseSpain, Austria, Switzerland, United Kingdom
-
Sunovion Respiratory Development Inc.CompletedChronic Obstructive Pulmonary Disease | COPDUnited States
-
Mundipharma Research LimitedCompletedChronic Obstructive Pulmonary DiseaseUkraine, United Kingdom, Spain, Bulgaria, South Africa, Russian Federation, Germany, Hungary, Lithuania, Slovakia, Macedonia, The Former Yugoslav Republic of, Latvia, Romania, Korea, Republic of, Poland
-
National Jewish HealthTerminated
-
University of ChicagoHill-RomCompletedAsthma | Chronic Obstructive Pulmonary Disease (COPD) | Undifferentiated Asthma/COPDUnited States
-
Bridgeport HospitalUnknown
-
AstraZenecaParexelCompletedSafety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy SubjectsChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States